Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ARIX.LSE
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Arix Bioscience PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Biotechnology
- Market cap
- 18.37B
- Ent value
- 18.27B
- Price/Sales
- 649.90
- Price/Book
- 76.84
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 818.94
- Forward P/E
- -
- PEG
- -
- EPS growth
- 17.03%
- 1 year return
- 24.56%
- 3 year return
- -10.64%
- 5 year return
- -2.72%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ARIX.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 818.94 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 1186.34 |
| EV to EBITDA | 1179.91 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 649.90 |
| Price to Book | 76.84 |
| EV to Sales | 646.38 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 129.39M |
| EPS (TTM) | 0.17 |
| FCF per share (TTM) | -0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 28.27M |
| Gross profit (TTM) | 15.02M |
| Operating income (TTM) | 15.18M |
| Net income (TTM) | 22.44M |
| EPS (TTM) | 0.17 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 53.13% |
| Operating margin (TTM) | 53.71% |
| Profit margin (TTM) | 79.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 100.99M |
| Net receivables | 0.00 |
| Total current assets | 103.36M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 90.00K |
| Total assets | 240.53M |
| Accounts payable | 1.38M |
| Short/Current long term debt | 37.00K |
| Total current liabilities | 1.41M |
| Total liabilities | 1.41M |
| Shareholder's equity | 239.12M |
| Net tangible assets | 239.12M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -2.70M |
| Capital expenditures (TTM) | 7.50K |
| Free cash flow (TTM) | -2.71M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 9.38% |
| Return on Assets | 9.33% |
| Return on Invested Capital | 9.38% |
| Cash Return on Invested Capital | -1.13% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ARIX.LSE | S&P500 | |
| Current price drop from All-time high | -36.04% | -0.04% |
| Highest price drop | -73.17% | -56.47% |
| Date of highest drop | 2 Apr 2020 | 9 Mar 2009 |
| Avg drop from high | -33.91% | -11.07% |
| Avg time to new high | 93 days | 12 days |
| Max time to new high | 786 days | 1805 days |
COMPANY DETAILS
Marketcap
18.37B
Marketcap category
Large-cap
Description
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
Employees
9
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found